Lucile Blaise's Insider Trades & SAST Disclosures
Lucile Blaise's most recent trade in Resmed Inc. was a trade of 135 ResMed Common Stock done at an average price of $144.0 . Disclosure was reported to the exchange on Nov. 13, 2023.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Lucile Blaise.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Resmed Inc. | Lucile Blaise | President, Sleep & RC Business | Payment of exercise price or tax liability using portion of securities received from the company at price $ 143.98 per share. | 13 Nov 2023 | 135 | 10,305 (0%) | 0% | 144.0 | 19,437 | ResMed Common Stock |
| Resmed Inc. | Lucile Blaise | President, Sleep & RC Business | Payment of exercise price or tax liability using portion of securities received from the company at price $ 165.97 per share. | 25 Aug 2023 | 379 | 10,355 (0%) | 0% | 166.0 | 62,903 | ResMed Common Stock |
| Resmed Inc. | Lucile Blaise | President, Sleep & RC Business | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Aug 2023 | 3,294 | 10,735 (0%) | 0% | 0 | ResMed Common Stock | |
| Resmed Inc. | Lucile Blaise | President, Sleep & RC Business | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Aug 2023 | 819 | 7,441 (0%) | 0% | 0 | ResMed Common Stock | |
| Resmed Inc. | Lucile Blaise | President, Sleep & RC Business | Payment of exercise price or tax liability using portion of securities received from the company at price $ 224.40 per share. | 21 Nov 2022 | 114 | 6,705 (0%) | 0% | 224.4 | 25,582 | ResMed Common Stock |
| Resmed Inc. | Lucile Blaise | President, Sleep & RC Business | Payment of exercise price or tax liability using portion of securities received from the company at price $ 224.40 per share. | 21 Nov 2022 | 78 | 6,627 (0%) | 0% | 224.4 | 17,503 | ResMed Common Stock |
| Resmed Inc. | Lucile Blaise | President, Sleep & RC Business | Payment of exercise price or tax liability using portion of securities received from the company at price $ 224.40 per share. | 21 Nov 2022 | 75 | 6,552 (0%) | 0% | 224.4 | 16,830 | ResMed Common Stock |
| Resmed Inc. | Lucile Blaise | President, Sleep & RC Business | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Nov 2022 | 2,410 | 2,410 | - | - | ResMed Common Stock Options | |
| Resmed Inc. | Lucile Blaise | President, Sleep & RC Business | Exercise or conversion of derivative security received from the company (such as an option) at price $ 225.18 per share. | 15 Nov 2022 | 516 | 7,504 (0%) | 0% | 225.2 | 116,193 | ResMed Common Stock |
| Resmed Inc. | Lucile Blaise | President, Sleep & RC Business | Sale of securities on an exchange or to another person at price $ 225.18 per share. | 15 Nov 2022 | 169 | 7,335 (0%) | 0% | 225.2 | 38,055 | ResMed Common Stock |
| Resmed Inc. | Lucile Blaise | President, Sleep & RC Business | Payment of exercise price or tax liability using portion of securities received from the company at price $ 225.18 per share. | 15 Nov 2022 | 169 | 6,819 (0%) | 0% | 225.2 | 38,055 | ResMed Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges